Literature DB >> 9597227

The level of human immunodeficiency virus (HIV) type 1 RNA in cerebrospinal fluid as a marker of HIV encephalitis.

P Bossi1, N Dupin, A Coutellier, F Bricaire, C Lubetzki, C Katlama, V Calvez.   

Abstract

We prospectively evaluated the level of human immunodeficiency virus (HIV) type 1 RNA in cerebrospinal fluid (CSF) as a marker of HIV encephalitis. Fifty-two HIV-1-infected patients (41 males and 11 females; mean age, 39 years) were tested for the presence of HIV-1 RNA in plasma and CSF. Samples of CSF were obtained by lumbar puncture to evaluate cognitive deficits, seizures, or fever among these patients. HIV encephalitis was diagnosed in 11 patients (21%), other CNS diseases were diagnosed in 12 (23%), and fever without CNS disease was diagnosed in 29 (56%). HIV-1 RNA was detectable in 92% of the plasma specimens and 75% of the CSF specimens. No significant difference was observed in CSF levels of HIV-1 RNA between patients with or without HIV encephalitis. CSF levels of HIV-1 RNA correlated with plasma levels of HIV-1 RNA (Spearman's rank correlation, +0.31; P = .02) and CSF white blood cell counts (Spearman's rank correlation, +0.4; P < .01). The absence of any significant difference between patients with or without HIV encephalitis suggests that the CSF HIV-1 RNA level is not a good marker for the diagnosis of HIV encephalitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9597227     DOI: 10.1086/520301

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

1.  New Thoughts on Pathogenesis and Diagnosis of Encephalitis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-06       Impact factor: 3.725

2.  Transmigration of macrophages across the choroid plexus epithelium in response to the feline immunodeficiency virus.

Authors:  Rick B Meeker; D C Bragg; Winona Poulton; Lola Hudson
Journal:  Cell Tissue Res       Date:  2012-01-27       Impact factor: 5.249

3.  Neurocognitive Impairment in the Combined Antiretroviral Therapy Era in a Romanian Cohort of Young Adults with Chronic HIV Infection.

Authors:  Aura Temereanca; Luminita Ene; Adelina Rosca; Carmen C Diaconu; Anca Luca; Ruxandra Burlacu; Roxana Radoi; Adina Bulacu-Talnariu; Thomas D Marcotte; Cristian L Achim; Simona Ruta
Journal:  AIDS Res Hum Retroviruses       Date:  2019-10-08       Impact factor: 2.205

4.  Peripheral and cerebrospinal fluid immune activation and inflammation in chronically HIV-infected patients before and after virally suppressive combination antiretroviral therapy (cART).

Authors:  E Merlini; F Iannuzzi; A Calcagno; F Bai; M Trunfio; A d'Arminio Monforte; S Bonora; Giulia Marchetti
Journal:  J Neurovirol       Date:  2018-07-09       Impact factor: 2.643

5.  Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation.

Authors:  C M McManus; K Weidenheim; S E Woodman; J Nunez; J Hesselgesser; A Nath; J W Berman
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

6.  Nuclear factor-kappa B family member RelB inhibits human immunodeficiency virus-1 Tat-induced tumor necrosis factor-alpha production.

Authors:  Michelle Kiebala; Oksana Polesskaya; Zhenqiang Yao; Seth W Perry; Sanjay B Maggirwar
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

7.  Stability of human immunodeficiency virus type 1 RNA in cerebrospinal fluid determined with the AMPLICOR HIV-1 MONITOR test, version 1.5 (ultrasensitive).

Authors:  Elyse J Singer; H Aaron Aronow; Shing-Yi Lee; Charles H Hinkin; Tadd Lazarus
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

8.  Evidence for predilection of macrophage infiltration patterns in the deeper midline and mesial temporal structures of the brain uniquely in patients with HIV-associated dementia.

Authors:  Li Zhou; Rejane Rua; Thomas Ng; Valentina Vongrad; Yung S Ho; Carolyn Geczy; Kenneth Hsu; Bruce J Brew; Nitin K Saksena
Journal:  BMC Infect Dis       Date:  2009-12-02       Impact factor: 3.090

9.  Valproic acid inhibits the release of soluble CD40L induced by non-nucleoside reverse transcriptase inhibitors in human immunodeficiency virus infected individuals.

Authors:  Donna C Davidson; Giovanni Schifitto; Sanjay B Maggirwar
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

10.  CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration.

Authors:  Sahra Abdulle; Asa Mellgren; Bruce J Brew; Paola Cinque; Lars Hagberg; Richard W Price; Lars Rosengren; Magnus Gisslén
Journal:  J Neurol       Date:  2007-04-10       Impact factor: 6.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.